Quince Therapeutics, Inc. short interest in 2019
In 2019, Quince Therapeutics, Inc.'s disclosed short interest ran from 2.09% of shares outstanding on 15 Oct 2019 to 5.77% on 31 Dec 2019, a change of +3.68 percentage points. The year's high was 5.77% on 31 Dec 2019 and its low 2.09% on 15 Oct 2019, averaging 3.20% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.90 days on 15 Oct 2019. Full history: Quince Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 2.09% (15 Oct 2019)
- End of year
- 5.77% (31 Dec 2019)
- Change
- +3.68 pp
- High
- 5.77% (31 Dec 2019)
- Low
- 2.09% (15 Oct 2019)
- Average
- 3.20%
- Highest days to cover
- 31.90 (15 Oct 2019)
- SEC filings marked
- 3
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 2.09% | 31.90 | 10-Q filed, 10-Q filed |
| 31 Oct 2019 | 2.29% | 23.41 | |
| 15 Nov 2019 | 2.48% | 12.13 | 10-Q filed |
| 29 Nov 2019 | 2.45% | 6.63 | |
| 13 Dec 2019 | 4.14% | 4.64 | |
| 31 Dec 2019 | 5.77% | 4.46 |
See also: Quince Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.